HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

European perspective on human polyomavirus infection, replication and disease in solid organ transplantation.

Abstract
Human polyomaviruses (HPyVs) are a growing challenge in immunocompromised patients in view of the increasing number of now 12 HPyV species and their diverse disease potential. Currently, histological evidence of disease is available for BKPyV causing nephropathy and haemorrhagic cystitis, JCPyV causing progressive multifocal leukoencephalopathy and occasionally nephropathy, MCPyV causing Merkel cell carcinoma and TSPyV causing trichodysplasia spinulosa, the last two being proliferative skin diseases. Here, the current role of HPyV in solid organ transplantation (SOT) was reviewed and recommendations regarding screening, monitoring and intervention were made. Pre-transplant screening of SOT donor or recipient for serostatus or active replication is currently not recommended for any HPyV. Post-transplant, however, regular clinical search for skin lesions, including those associated with MCPyV or TSPyV, is recommended in all SOT recipients. Also, regular screening for BKPyV replication (e.g. by plasma viral load) is recommended in kidney transplant recipients. For SOT patients with probable or proven HPyV disease, reducing immunosuppression should be considered to permit regaining of immune control. Antivirals would be desirable for treating proven HPyV disease, but are solely considered as adjunct local treatment of trichodysplasia spinulosa, whereas surgical resection and chemotherapy are key in Merkel cell carcinoma. Overall, the quality of the clinical evidence and the strength of most recommendations are presently limited, but are expected to improve in the coming years.
AuthorsH H Hirsch, N Babel, P Comoli, V Friman, F Ginevri, A Jardine, I Lautenschlager, C Legendre, K Midtvedt, P Muñoz, P Randhawa, C H Rinaldo, A Wieszek, ESCMID Study Group of Infection in Compromised Hosts
JournalClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (Clin Microbiol Infect) Vol. 20 Suppl 7 Pg. 74-88 (Sep 2014) ISSN: 1469-0691 [Electronic] England
PMID24476010 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Copyright© 2014 The Authors Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases.
Chemical References
  • Immunosuppressive Agents
Topics
  • Epidemiological Monitoring
  • Europe (epidemiology)
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents (therapeutic use)
  • Infection Control (methods)
  • Mass Screening
  • Organ Transplantation
  • Polyomavirus Infections (diagnosis, epidemiology, prevention & control)
  • Transplant Recipients

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: